The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Charles River Laboratories International Inc

NYSE: CRL
Last

(U.S.) $77.70

Today's change+1.09 +1.42%
Updated March 5 4:04 PM EST. Delayed by at least 15 minutes.
 

Charles River Laboratories International Inc

NYSE: CRL
Last

(U.S.) $77.70

Today's change+1.09 +1.42%
Updated March 5 4:04 PM EST. Delayed by at least 15 minutes.

Charles River Laboratories International Inc Hits New 52-week High

Charles River Laboratories International Inc closed up Thursday by (U.S.)$1.09 or 1.42% to (U.S.)$77.70 and setting a new 52-week high. Over the last five days, shares have gained 1.21% and 22.09% year to date. Shares have outperformed the S&P 500 by 21.13% during the last year.

Key company metrics

  • Open(U.S.) $76.80
  • Previous close(U.S.) $76.61
  • High(U.S.) $77.96
  • Low(U.S.) $76.76
  • Bid / Ask-- / --
  • YTD % change+22.09%
  • Volume518,164
  • Average volume (10-day)454,147
  • Average volume (1-month)506,358
  • Average volume (3-month)396,856
  • 52-week range(U.S.) $49.60 to (U.S.) $77.96
  • Beta1.10
  • Trailing P/E28.78×
  • P/E 1 year forward21.54×
  • Forward PEG2.35×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.70
Updated March 5 4:04 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.01%

Based on its net profit margin of 10.01%, Charles River Laboratories International Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.13%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 27, 201412/27/2014Sep 27, 201409/27/2014Jun 28, 201406/28/2014Mar 29, 201403/29/2014
Revenue330328341299
Total other revenue--------
Total revenue330328341299
Gross profit120118126109
Total cost of revenue210209216191
Total operating expense289281290260
Selling / general / administrative68646865
Research & development--------
Depreciation / amortization7874
Interest expense (income), net operating--------
Unusual expense (income)4------
Other operating expenses, total--------
Operating income41465140
Interest income (expense), net non-operating-3-3-3-3
Gain (loss) on sale of assets--------
Other--------
Income before tax40445143
Income after tax29323633
Income tax, total12121410
Net income27323532
Total adjustments to net income--------
Net income before extra. items28323633
Minority interest-10-10
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items28323633
Inc. avail. to common incl. extra. items27323532
Diluted net income27323532
Dilution adjustment00--0
Diluted weighted average shares48474848
Diluted EPS excluding extraordinary itemsvalue per share0.590.680.750.68
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share1.340.690.800.70